Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study.
Christina Schindera, Claudia Elisabeth Kuehni, Mladen Pavlovic...
https://pubmed.ncbi.nlm.nih.gov/32269016/Actively Recruiting
Led by University of Bern · Updated on 2026-05-29
500
Participants Needed
6
Research Sites
N/A
Total Duration
This research investigates early heart dysfunction in adults who survived childhood cancer. It focuses on detecting heart problems sooner using a new echocardiographic method called speckle tracking compared to standard echocardiography. The study aims to improve early diagnosis of heart issues, which are a leading cause of death unrelated to cancer in this group. Participants receive detailed heart evaluations including conventional and speckle tracking echocardiography, cardiopulmonary exercise testing, and other assessments such as physical exams and questionnaires about lifestyle and fatigue. The study compares survivors treated with potentially heart-affecting therapies like anthracyclines or chest radiation high risk to those treated with other chemotherapy standard risk. During the study visit, survivors undergo a thorough cardiac assessment with tests like electrocardiograms, exercise tests, and quality of life surveys. Researchers measure the presence of heart dysfunction and impaired exercise capacity, and evaluate treatment-related risk factors. Follow-up evaluations may be performed if clinically needed. The study is conducted at the University Hospital Bern, Switzerland, and participation requires written consent with no upper age limit specified.
CONDITIONS
Cardiac Dysfunction in Childhood Cancer Survivors
C
Claudia E Kuehni, MD
C
Christina Schindera, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Bern
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a detailed cardiac assessment including personal history, physical examination, electrocardiogram, echocardiography, exercise testing, and questionnaires on health and lifestyle.
1 visit (in-person)
Duration - Ongoing as clinically indicated
Participants are monitored longitudinally based on clinical indications to detect any cardiac dysfunction over time.
Follow-up visits as needed depending on clinical findings
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Christina Schindera, Claudia Elisabeth Kuehni, Mladen Pavlovic...
https://pubmed.ncbi.nlm.nih.gov/32269016/University of Bern
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborating Sponsor